Upgraded Calming CBD Salves

💊 While topical cannabinoid products continue to proliferate in retail markets with marketing claims of calming effects, clinicians should recognize that the evidence base for their efficacy remains limited and heterogeneous, with most supporting data derived from preclinical or in vitro studies rather than rigorous clinical trials. The lack of standardized formulations, potency verification, and regulatory oversight for these products means that “higher-concentration” claims are difficult to validate independently, and patients may experience variable effects or unintended interactions with concurrent medications. Additionally, botanical blends combining multiple cannabinoids introduce further complexity in attributing effects to specific compounds or understanding potential synergistic interactions. Clinicians should remain appropriately skeptical of patient reports of benefit while maintaining an open dialogue about their use, particularly for patients exploring alternatives for anxiety or pain management, and should counsel patients that topical cannabinoid products are not replacements for evidence-based treatments. When patients inquire